πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 93 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8258122

3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives

Almirall, S.A. Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8242177

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the Ξ²2 adrenergic receptor

Almirall, S.A. Β· Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8178679

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the Ξ²2 adrenergic receptors

Almirall, S.A. Β· Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8129405

Quinuclidine derivatives and medicinal compositions containing the same

Almirall Prodesfarma S.A. Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964615

Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the Ξ²2 adrenergic receptor

Almirall, S.A. Β· Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7960383

Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

Laboratories Almirall, S.A. Β· Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906530

1,7-naphthyridine derivatives as p38 MAP kinase inhibitors

Laboratories Almirall, S.A. Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7897617

Quinuclidine derivatives and medicinal compositions containing the same

Almirall Prodesfarma S.A. Β· Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7893087

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7879874

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7855202

Imidazopyridine derivatives as A2B adenosine receptor antagonists

Laboratories Almirall, S.A. Β· Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7790728

Pyrazine derivatives useful as adenosine receptor antagonists

Laboratories Almirall, S.A. Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776879

Quinuclidine carbamate derivatives and their use as M3 antagonists

Almirall, S.A. Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7750023

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. Β· Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7718670

Quinuclidine amide derivatives

Laboratories Almirall, S.A. Β· Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662814

4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors

Laboratories Almirall, S.A. Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622480

Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents

Laboratories Almirall, S.A. Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582676

2-phenylpyran-4-one derivatives as selective COX-2 inhibitors

Laboratories Almirall, S.A. Β· Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560471

Indolylpiperidine derivatives as potent antihistaminic and antiallergic agents

Laboratories Almirall, S.A. Β· Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7557212

Tricyclic derivatives as LTD4 antagonists

Laboratories Almirall, S.A. Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7511038

Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

Laboratories Almirall, S.A. Β· Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7504398

Substituted-4-(pyrrolo pyrimidin-6-yl)benzenesulphonamide derivatives

Laboratories Almirall, S.A. Β· Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7491722

Pyridazin-3(2H)-one derivatives

Laboratories Almirall, S.A. Β· Granted Tue Feb 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7488735

Quinuclidine amide derivatives

Laboratories Almirall, S.A. Β· Granted Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted